Home Cart 0 Sign in  
X

[ CAS No. 263400-88-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 263400-88-0
Chemical Structure| 263400-88-0
Chemical Structure| 263400-88-0
Structure of 263400-88-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 263400-88-0 ]

Related Doc. of [ 263400-88-0 ]

Alternatived Products of [ 263400-88-0 ]

Product Details of [ 263400-88-0 ]

CAS No. :263400-88-0 MDL No. :MFCD22124592
Formula : C11H16O5S2 Boiling Point : -
Linear Structure Formula :- InChI Key :AXUFUWARAAYMCG-UHFFFAOYSA-N
M.W : 292.37 Pubchem ID :22732325
Synonyms :

Calculated chemistry of [ 263400-88-0 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.45
Num. rotatable bonds : 6
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 68.97
TPSA : 94.27 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.98
Log Po/w (XLOGP3) : 1.18
Log Po/w (WLOGP) : 3.3
Log Po/w (MLOGP) : 1.66
Log Po/w (SILICOS-IT) : 1.12
Consensus Log Po/w : 1.85

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.25
Solubility : 1.66 mg/ml ; 0.00567 mol/l
Class : Soluble
Log S (Ali) : -2.76
Solubility : 0.514 mg/ml ; 0.00176 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.97
Solubility : 0.0313 mg/ml ; 0.000107 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.99

Safety of [ 263400-88-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 263400-88-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 263400-88-0 ]
  • Downstream synthetic route of [ 263400-88-0 ]

[ 263400-88-0 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 2058-49-3 ]
  • [ 98-59-9 ]
  • [ 263400-88-0 ]
YieldReaction ConditionsOperation in experiment
83% With triethylamine In dichloromethane for 12 h; Inert atmosphere 4-Methylbenzene-1-sulfonyl chloride (759 mg, 3.98 mmol), 3-(methylsulfonyl)propan- 1-ol (500 mg, 3.62 mmol) and triethyl amine (0.555 ml_, 3,98 mmol) were dissolved in Dichloromethane Dry (5 mL) under nitrogen atmosphere, and the mixture was stirred for 12 hours. The solvent was removed under reduced pressure and the residue was purified by semi-preparative HPLC-UV, to afford 3-(methylsulfonyl)propyl 4- methylbenzenesulfonate (881 mg, Y = 83percent) as a white solid. MS (ESi+) m/z: 293.1 [M+H]+. (0255) Tert-butyl (4-hydroxy-2,6-dimethylphenyl)carbamate (which was synthesized as reported in the synthesis of compound 34) (269 mg, 1.13 mmol), 3- (methysulfonyl)propyl 4-methybenzenesulfonate (398 mg, 1.36 mmol) and potassium carbonate (188 mg, 1.36 mmol) were dissolved in N,N-Dimethylformamide Dry (2.5 ml) and the mixture was stirred at 80°C under nitrogen atmosphere for 12 hours. AcOEt (20 mL) was added, and the mixture was washed with brine (2 x 0 mL). The organic layer was concentrated under reduced pressure and the residue was purified by semi-preparative HPLC-UV, to afford tert-butyl (2,6-dimethyl-4-(3- (methylsulfonyl)propoxy)pheny[)carbamate (375 mg, Y = 93percent) as a white solid. MS (ESI+) m/z: 380.2 [ +Naf . (0256) Starting from tert-butyl (2,6-dimethyl-4-(3-(methylsulfonyl)propoxy)phenyl)carbamate (375 mg, 1.05 mmol), 2,6-dimethyl-4-(3-(methylsulfonyl)propoxy)aniline, hydrochloride salt (309 mg, Y = quant.) was obtained as reported in the synthesis of compound 34. MS (ESI+) m/z: 258.1 [M+H]+. (0257) Starting from 2,6-dimethyl-4-(3-(methysulfonyl)propoxy)aniline, hydrochloride salt (46.1 mg, 0.157 mmoi) methyl 7-(3-(N-(2,6-dimethyl-4-(3- (methylsulfonyl)propoxy)phenyl)sulfamoyl) (0258) phenyl)heptanoate was obtained (33 mg, Y = 39percent) as described in Procedure A. MS (ESI+) m/z: 562.3 [M+Na]+. (0259) Compound 35 was then obtained by hydrolysis of the ester derivative (20 mg, 0.046 mmol) as described for compound 1 , as a white solid (23 mg, Y = 83percent). 1H NMR (300 MHz, CHLOROFORM-d) δ ppm 1.24 - 1.43 (m, 4 H) 1.51 - 1 .67 (m, 4 H) 1 .96 (s, 6 H) 2.26 - 2.41 (m, 4 H) 2.61 (t, J=7.58 Hz, 2 H) 2.97 (s, 3 H) 3.22 - 3.31 (m, 2 H) 4.04 (t, .7=5.68 Hz, 2 H) 6.32 (br s, 1 H) 6.52 (s, 2 H) 7.33 - 7.41 (m, 2 H) 7.48 - 7.58 (m, 2 H) 9.36 (br s, 2 H). MS (ESI+) m/z: 526.2 [M+H]+.
1.6 g With pyridine In dichloromethane at 0 - 20℃; for 12 h; To a solution of 3-(methylsulfonyl)propan-1 -ol (1 .0 g) in dichloromethane (10 mL) and pyridine (1 .5 mL) is added at 0°C p-toluene-sulfonylchloride (1 .38 g) in portions. The mixture is stirred for 12 hours at room temperature, diluted with dichloromethane and washed with 1 M aqueous HCI solution and brine. After drying (MgSO4) the solvent is evaporated to give the title compound. Yield: 1 .6 g; LC (method 1 ): tR = 0.82 min; Mass spectrum (ESI+): m/z = 293 [M+H]+.
Reference: [1] Patent: WO2018/29150, 2018, A1, . Location in patent: Page/Page column 37-38
[2] Patent: WO2013/144098, 2013, A1, . Location in patent: Page/Page column 96
[3] Patent: WO2015/89809, 2015, A1, . Location in patent: Page/Page column 62
[4] Patent: WO2015/95256, 2015, A1, . Location in patent: Page/Page column 62; 63
[5] Patent: WO2017/13046, 2017, A1, . Location in patent: Page/Page column 34-35
  • 2
  • [ 187722-18-5 ]
  • [ 263400-88-0 ]
YieldReaction ConditionsOperation in experiment
98% With Oxone In methanol; water at 0 - 20℃; for 3 h; To a solution of 16A (2.16 g, 8.31 mmol) in MeOH (44 mL) cooled to 0 °C was added a solution of OXONE® (10.2 g, 16.6 mmol) in water (44 mL). The ice bath was allowed to gradually warm to rt and the reaction mixture was stirred for 3 h. The MeOH was removed under reduced pressure and the reaction mixture was diluted with water. The aqueous layer was extracted with EtOAc (3x) and the combined organic layers were washed with brine, dried (MgS04), and concentrated to give 16B (2.39 g, 8.17 mmol, 98percent> yield) as a white solid. LC-MS Anal. Calc'd for CnHi605S2: 292.37, found [M+H] 293.0.
96% With Oxone In methanol; water at 0℃; for 20 h; To a solution of 3- (methylthio) propyl 4- 5 methylbenzenesulfonate (12.2 g) in methanol, (250 ml) was added EPO <DP n="223"/>dropwise a solution of Oxone (trade name) (57.7 g) in water (250 ml) under ice-cooling. After completion of the dropwise addition, and the mixture was stirred for 20 hr while allowing to warm to room temperature. Methanol was evaporated under reduced pressure, and the mixture was diluted with water. The organic product was extracted with ethyl acetate. The extract was washed with saturated brine, dried (Na2SO4), and concentrated under reduced pressure. The precipitated crystals were washed with ethyl acetate-heptane to give 3- (methylsulfonyl) propyl 4-methylbenzenesul;fonate (13.1 g, yield: 96percent) as colorless crystals. MS m/z 293 (MH+).
96% With Oxone In methanol; water at 0 - 20℃; for 20 h; Reference Example 16; 3- (methylsulfonyl) propyl A- methylbenzenesulfonate; To a solution of 3- (methylthio) propyl A- methylbenzenesulfonate (12.2 g, 46.9 mmol) in methanol (250 mL) was added dropwise a solution of potassium peroxysulfate (trade name: OXONE, 57.7 g, 93.8 mmol) in water (250 mL) under ice-cooling. After completion of the dropwise addition, the mixture was stirred for 20 hr, during which the mixture was allowed to gradually warm to room temperature. Methanol was <n="81"/>evaporated under reduced pressure, and the mixture was diluted with water, and the organic material was extracted with ethyl acetate. The extract was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The precipitated crystals were washed with ethyl acetate-heptane to give the title compound (13.1 g, yield 96percent) as colorless crystals. MS m/z 293 (M + H)+.
92% With Oxone In methanol; water at 20℃; for 20 h; Cooling with ice (B) To an ice-cooled solution of 3-(methylthio)propyl 4-methylbenzenesulfonate (3.6 g; 13.8 mmol) in MeOH (70 mL) was added a suspension of monopersulfate compound (17 g; 27.4 mmol) in water (70 mL) in a portion-wise fashion. Upon completion of the addition, the mixture was allowed to warm to rt, and stirring was continued for 20 h. The reaction was partially concentrated to remove the MeOH and the mixture was further diluted with water and extracted with EtOAc (2x). The combined organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. The residue was purified by silica gel chromatography eluting with 0– 67percent EtOAc in hexanes to afford 3- (methylsulfonyl)propyl 4-methylbenzene-sulfonate (3.72 g, 92percent) as a white solid. LC/MS: mass calcd. for C11H16O5S2: 292.38, found 315.1 [M+Na]+.
92% With Oxone In methanol; water at 20℃; for 20 h; Cooling with ice (B)
To an ice-cooled solution of 3-(methylthio)propyl 4-methylbenzenesulfonate (3.6 g; 13.8 mmol) in MeOH (70 mL) was added a suspension of monopersulfate compound (17 g; 27.4 mmol) in water (70 mL) in a portion-wise fashion.
Upon completion of the addition, the mixture was allowed to warm to rt, and stirring was continued for 20 h.
The reaction was partially concentrated to remove the MeOH and the mixture was further diluted with water and extracted with EtOAc (2*).
The combined organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure.
The residue was purified by silica gel chromatography eluting with 0-67percent EtOAc in hexanes to afford 3-(methylsulfonyl)propyl 4-methylbenzene-sulfonate (3.72 g, 92percent) as a white solid. LC/MS: mass calcd. for C11H16O5S2: 292.38, found 315.1 [M+Na]+.
92% With monopersulfate In methanol; water at 20℃; for 20 h; (B) To an ice-cooled solution of 350 3-(methylthio)propyl 4-methylbenzenesulfonate (3.6 g; 13.8 mmol) in 21 MeOH (70 mL) was added a suspension of monopersulfate compound (17 g; 27.4 mmol) in 12 water (70 mL) in a portion-wise fashion. Upon completion of the addition, the mixture was allowed to warm to rt, and stirring was continued for 20 h. The reaction was partially concentrated to remove the MeOH and the mixture was further diluted with water and extracted with EtOAc (2×). The combined organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. The residue was purified by silica gel chromatography eluting with 0-67percent EtOAc in hexanes to afford 352 3-(methylsulfonyl)propyl 4-methylbenzene-sulfonate (3.72 g, 92percent) as a white solid. LC/MS: mass calcd. for C11H16O5S2: 292.38, found 315.1 [M+Na]+.
90% With oxone In methanol at 20℃; Cooling with ice 3-(methylthio)propyl-4-methylbenzenesulfonate (12.5 g, 48 mmol) was added to 250 mL in an ice bathStirring in a methanol solution, adding Oxone (59 g, 96 mmol) dropwise to the reaction solution, returning to room temperature, and stirring overnight. thenThe reaction solution was concentrated under reduced pressure, and a large amount of a white solid precipitated, which was filtered and washed with water to give a white solid (12.6 g) in a yield of 90percent.
1.95 g With oxone In methanol; water at 0 - 20℃; for 20 h; Step 1: Preparation of 3-methylsulfonylpropyl 4-methylbenzenesulfonate To a solution of 3-methylsulfanylpropyl 4-methylbenzenesulfonate (2 g, 7.7 mmol) in methanol (50 mL) was added a solution of oxone (9.47 g, 15.4 mmol) in water (50 mL) dropwise at 0 oC. After being warmed to rt and stirred at rt for 20 hrs, the mixture was filtered and the filtrate was extracted with EA (50 mL) for three times. The combined organic layer was washed with water, dried over anhydrous Na2SO4 and concentrated in vacuo to give 3- methylsulfonylpropyl 4-methylbenzenesulfonate as a white solid (1.95 g) which was used in the next step directly without further purification.
38 g With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 0℃; To a solution of 3-(Methylthio)-1-propanol (20g, 0.19mol) and TEA (66ml, 0.48mol) in DCM (800mL) cooled at 0°C was added p-toluenesulfonyl chloride (44g, 0.23mol, dissoloved in 200mL DCM) dropwise. After addtion, the mixture was then stirred at r.t. overnight. After the reaction was complete, the resluting solution was washed with saturated Na2CO3 solution, brine, dried over MgSO4 and concentrated in vacuo to give the crude of 3-methylsulfanylpropyl 4-methylbenzenesulfonate, which was used in the next step without further purification. To the solution of the crude of 3-methylsulfanylpropyl 4-methylbenzenesulfonate (prepared above) in DCM (200 mL) cooled at 0oC was added m-CPBA (66g, 0.39mol) slowly and the mixture was then stirred at rt overnight. After the reaction was complete, the mixture was washed with saturated sodium thiosulfate (300mL) 3 times , saturated sodium bicarbonate (300mL) 3 times, dried over MgSO4 and then concentrated in vacuo to give 3-methylsulfonylpropyl 4-methylbenzenesulfonate (11b, 38g, 69percent yield over 2 steps) as a white solid. To a solution of tert-butyl 4-chloro-2-nitrophenylcarbamate (580 mg, 2.1 mmol) in DMF(5mL) cooled at 0oC was added NaH( 169 mg, 4.4 mmol). The mixture was then stirred at rt for 30mins. Then to the resulting solution was added 3-methylsulfonylpropyl 4-methylbenzenesulfonate (11b, 750 mg, 2.6 mmol) and the mixture was stirred at 50oC overnight. After the reaction was complete, to the mixture was added water (30 mL) and the resulting mixture was extracted with DCM (50 mL) 3 times. The combined organic layer was washed with brine, dried over MgSO4 and concentrated in vacuo. The residue was purified by column chromatography on silica gel (elution with DCM:MeOH 20 :1) to give tert-butyl N-(4-chloro-2-nitro-phenyl)-N-(3-methylsulfonylpropyl)carbamate(11c, 360 mg, 69percent yield). To a soltuion of tert-butyl N-(4-chloro-2-nitro-phenyl)-N-(3-methylsulfonylpropyl)carbamate (11c, 360 mg, 1.45 mol) in MeOH (10 mL) was added 2percent Pt/C (50mg) under N2 atmosphere, the mixture wa then hydrogenated at rt for 3 hours. After the reaction was complete, the mixture was filtred and the filtrate was concentrated in vacuo to give the crude of tert-butyl N-(2-amino-4-chloro-phenyl) -N-(3-methylsulfonylpropyl)carbamate (11d, 330 mg, 100percent yield), which was used in the next step directly without further purificaton. A mixture of tert-butyl N-(2-amino-4-chloro-phenyl)-N-(3-methylsulfonylpropyl)carbamate (11d, 320 mg, 0.92mmol) and sodium chloroacetate (130 mg, 1.1 mmol) in 4N HCl (15 mL) was stirred to 100oC overnight. After the reaction was complete, The reaction was concentrated in vacuo and the residue was redissoved in DCM (100 mL). The resulting soltuion was washed with saturated NaHCO3 (50 mL), brine (50 mL), dried over MgSO4 and concentrated in vacuo. The residue was purified by column crhomatography on silica gel (elution with DCM/EtOAc=3/1) to give 5-chloro-2-(chloromethyl) -1-(3-methylsulfonylpropyl)benzimidazole (11e, 130 mg, 44percent yield). To a mixture of 2-(methylsulfonyl)-1H-indole (72 mg, 0.37 mmol) and 5-chloro-2-(chloromethyl) -1-(2- (methylsulfonyl)ethyl)-1H-benzo[d]imidazole (11e, 120 mg, 0.37mmol) in DMF (3 mL) was added K2CO3 (104 mg, 0.74 mmol) and the mixture was stirred at rt overnight. After the reaction was completed, the mixture was filtered and the filtrate was purified by preparative HPLC to give 5-chloro-2-[(3-methylsulfonylindol-1-yl)methyl]-1-(3-methylsulfonylpropyl)benzimidazole (11, 100 mg, 78percent). MS: calcd (MH+) 480.1, exp (MH+) 480.1. 1H NMR(DMSO-d6, 400MHz):δ8.29(s, 1H), 7.80-7.86(m, 1H), 7.65-7.73(m, 3H), 7.26-7.34(m, 3H), 5.92(s, 2H), 4.86(t, J=7.6Hz, 2H), 3,73(br, 3H), 3.19(t, J=8.0Hz, 2H), 2.96(s, 3H), 2.08(t, J=7.6Hz, 2H); 13C NMR (101MHz, DMSO-d6) δ151.4, 143.2, 137.3, 134.7, 134.6, 126.9, 124.2, 123.8, 123.3, 122.6, 119.5, 119.2, 115.5, 112.4, 112.3, 51.1, 45.6, 43.6, 42.3, 23.1.  

Reference: [1] Patent: WO2015/171722, 2015, A1, . Location in patent: Page/Page column 102
[2] Patent: WO2007/18314, 2007, A2, . Location in patent: Page/Page column 221-222
[3] Patent: WO2008/1931, 2008, A2, . Location in patent: Page/Page column 79-80
[4] Journal of Medicinal Chemistry, 2012, vol. 55, # 8, p. 3960 - 3974
[5] Patent: WO2016/57731, 2016, A1, . Location in patent: Page/Page column 97
[6] Patent: US2017/290800, 2017, A1, . Location in patent: Page/Page column 0473
[7] Patent: US2017/291908, 2017, A1, . Location in patent: Paragraph 0472
[8] Patent: CN108003074, 2018, A, . Location in patent: Paragraph 0117; 0118; 0121; 0122
[9] Patent: WO2006/46031, 2006, A1, . Location in patent: Page/Page column 79-80
[10] Patent: WO2012/111849, 2012, A1, . Location in patent: Page/Page column 153
[11] Patent: WO2014/22528, 2014, A1, . Location in patent: Page/Page column 94; 95
[12] Patent: WO2014/19186, 2014, A1, . Location in patent: Page/Page column 80; 81
[13] Patent: WO2015/24526, 2015, A1, . Location in patent: Page/Page column 30
[14] Patent: WO2015/51496, 2015, A1, . Location in patent: Page/Page column 74; 75
[15] Patent: WO2015/51725, 2015, A1, . Location in patent: Page/Page column 72; 73
[16] Patent: US2016/24063, 2016, A1, . Location in patent: Paragraph 0286-0288
[17] Patent: CN103030646, 2016, B, . Location in patent: Paragraph 0477; 0479-0482
[18] Patent: WO2016/177655, 2016, A1, . Location in patent: Page/Page column 108
[19] European Journal of Medicinal Chemistry, 2017, vol. 138, p. 1147 - 1157
[20] Patent: EP3207928, 2017, A2, . Location in patent: Paragraph 0180-0182
  • 3
  • [ 505-10-2 ]
  • [ 98-59-9 ]
  • [ 263400-88-0 ]
YieldReaction ConditionsOperation in experiment
82%
Stage #1: With dmap; triethylamine In dichloromethane at 20℃; for 3 h;
Stage #2: With 3-chloro-benzenecarboperoxoic acid In dichloromethane; water at 20℃; for 2 h;
Weigh 3-methylthio-propanol (5·3g, 50mmol), triethylamine (13.9mL, 100mmol), DMAP (1.2g, 10mmol), was dissolved in 150mL dichloromethane burning added portionwise to toluenesulfonyl chloride (14.3g, 75mmol), stirred at room temperature for 3 hours until oxidation with potassium permanganate solution color, all of the alcohol the reaction was complete. 150mL was added in the reaction system was diluted with dichloromethane, washed with 1N aqueous hydrochloric acid, water, saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated to give crude product (11. 27g) direct investment in the next reaction. Previous resulting product (11. 27g, 38. 5mmol) was dissolved in 100mL of dichloromethane, cooled to ice-water bath 0° C, with stirring. In addition to 77percent mCPBA (17. 3g, 77.1 mmol) was dissolved in 100mL of dichloromethane, dropwise using a dropping funnel to the reaction system, naturally to room temperature after the addition was complete, stirring was continued for 2 hours, until the starting material the reaction was complete. Suction filtration funnel to remove solids and the resulting dichloromethane solution was burned, washed with 1N aqueous hydrochloric acid, water, saturated brineWashed with water, dried over anhydrous sodium sulfate, filtered, and concentrated to give the crude product was purified by flash column chromatography (50percent ethyl acetate / petroleum ether) to afford the product YZ-1 (12. 0g), two step yield 82percent.
Reference: [1] Patent: CN103145663, 2016, B, . Location in patent: Paragraph 0103-0105
  • 4
  • [ 187722-18-5 ]
  • [ 263400-88-0 ]
Reference: [1] Patent: US6593333, 2003, B1,
  • 5
  • [ 98-59-9 ]
  • [ 263400-88-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 8, p. 3960 - 3974
[2] Patent: WO2012/111849, 2012, A1,
[3] Patent: WO2014/19186, 2014, A1,
[4] Patent: WO2014/22528, 2014, A1,
[5] Patent: WO2015/24526, 2015, A1,
[6] Patent: WO2015/51496, 2015, A1,
[7] Patent: WO2015/51725, 2015, A1,
[8] Patent: WO2015/171722, 2015, A1,
[9] Patent: WO2016/57731, 2016, A1,
[10] Patent: WO2016/177655, 2016, A1,
[11] European Journal of Medicinal Chemistry, 2017, vol. 138, p. 1147 - 1157
[12] Patent: US2017/290800, 2017, A1,
[13] Patent: US2017/291908, 2017, A1,
[14] Patent: CN108003074, 2018, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 263400-88-0 ]

Aryls

Chemical Structure| 599-91-7

[ 599-91-7 ]

Propyl 4-methylbenzenesulfonate

Similarity: 0.87

Chemical Structure| 778-28-9

[ 778-28-9 ]

Butyl 4-methylbenzenesulfonate

Similarity: 0.86

Chemical Structure| 5469-66-9

[ 5469-66-9 ]

Propane-1,3-diyl bis(4-methylbenzenesulfonate)

Similarity: 0.86

Chemical Structure| 40412-06-4

[ 40412-06-4 ]

2-(Thiophen-2-yl)ethyl 4-methylbenzenesulfonate

Similarity: 0.86

Chemical Structure| 80-40-0

[ 80-40-0 ]

Ethyl 4-methylbenzenesulfonate

Similarity: 0.86

Sulfonates

Chemical Structure| 599-91-7

[ 599-91-7 ]

Propyl 4-methylbenzenesulfonate

Similarity: 0.87

Chemical Structure| 778-28-9

[ 778-28-9 ]

Butyl 4-methylbenzenesulfonate

Similarity: 0.86

Chemical Structure| 5469-66-9

[ 5469-66-9 ]

Propane-1,3-diyl bis(4-methylbenzenesulfonate)

Similarity: 0.86

Chemical Structure| 40412-06-4

[ 40412-06-4 ]

2-(Thiophen-2-yl)ethyl 4-methylbenzenesulfonate

Similarity: 0.86

Chemical Structure| 80-40-0

[ 80-40-0 ]

Ethyl 4-methylbenzenesulfonate

Similarity: 0.86

Sulfones

Chemical Structure| 357913-53-2

[ 357913-53-2 ]

3-(Methylsulfonyl)propyl methanesulfonate

Similarity: 0.57

Chemical Structure| 22381-54-0

[ 22381-54-0 ]

2-Tosylethanol

Similarity: 0.55

Chemical Structure| 3185-99-7

[ 3185-99-7 ]

1-Methyl-4-(methylsulfonyl)benzene

Similarity: 0.54

Chemical Structure| 22821-77-8

[ 22821-77-8 ]

4-(Methylsulfonyl)benzyl Alcohol

Similarity: 0.54

Chemical Structure| 220798-39-0

[ 220798-39-0 ]

(3-(Methylsulfonyl)phenyl)methanol

Similarity: 0.54